360 related articles for article (PubMed ID: 11832207)
1. The role of PML in tumor suppression.
Salomoni P; Pandolfi PP
Cell; 2002 Jan; 108(2):165-70. PubMed ID: 11832207
[TBL] [Abstract][Full Text] [Related]
2. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
Yang S; Jeong JH; Brown AL; Lee CH; Pandolfi PP; Chung JH; Kim MK
J Biol Chem; 2006 Sep; 281(36):26645-54. PubMed ID: 16835227
[TBL] [Abstract][Full Text] [Related]
4. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
5. Role of the promyelocytic leukaemia protein in cell death regulation.
Salomoni P; Dvorkina M; Michod D
Cell Death Dis; 2012 Jan; 3(1):e247. PubMed ID: 22237204
[TBL] [Abstract][Full Text] [Related]
6. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
7. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation in acute promyelocytic leukemia.
Lin RJ; Sternsdorf T; Tini M; Evans RM
Oncogene; 2001 Oct; 20(49):7204-15. PubMed ID: 11704848
[TBL] [Abstract][Full Text] [Related]
9. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
11. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
12. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
13. Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha.
Dong S; Stenoien DL; Qiu J; Mancini MA; Tweardy DJ
Mol Cell Biol; 2004 May; 24(10):4465-75. PubMed ID: 15121864
[TBL] [Abstract][Full Text] [Related]
14. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
15. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
18. Deconstructing PML-induced premature senescence.
Bischof O; Kirsh O; Pearson M; Itahana K; Pelicci PG; Dejean A
EMBO J; 2002 Jul; 21(13):3358-69. PubMed ID: 12093737
[TBL] [Abstract][Full Text] [Related]
19. Role of PML in cell growth and the retinoic acid pathway.
Wang ZG; Delva L; Gaboli M; Rivi R; Giorgio M; Cordon-Cardo C; Grosveld F; Pandolfi PP
Science; 1998 Mar; 279(5356):1547-51. PubMed ID: 9488655
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
